SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novo Nordisk A/S Data Show That Ultra-Long-Acting Insulin Degludec Can Be Flexibly Dosed at Any Time of the Day at a Different Time from Day to Day in People with Type 2 Diabetes